|
WO2020227120A1
|
|
Pierceable plug for needle
|
|
US2019201559A1
|
|
Methods for making ultrasound contrast agents
|
|
US2019255197A1
|
|
Methods for making ultrasound contrast agents
|
|
TW201800082A
|
|
Methods and devices for preparation of ultrasound contrast agents
|
|
US9789210B1
|
|
Methods for making ultrasound contrast agents
|
|
WO2016109400A2
|
|
Lipid-encapsulated gas microsphere compositions and related methods
|
|
EP3204950A1
|
|
Sealing container and method of use
|
|
WO2015160981A1
|
|
Methods and devices for isolating lead 203
|
|
AU2015200027A1
|
|
Contrast agents for applications including perfusion imaging
|
|
EP3212240A1
|
|
Lipid encapsulated gas microsphere compositions and related methods
|
|
SG10201903357VA
|
|
Lipid encapsulated gas microsphere compositions and related methods
|
|
WO2014143725A1
|
|
Control system for radiopharmaceuticals
|
|
TW201514188A
|
|
Process for manufacture of gadofosveset trisodium monohydrate
|
|
CN109125745A
|
|
Radiopharmaceutical synthetic method
|
|
AU2013203000A1
|
|
Compositions, methods, and systems for the synthesis and use of imaging agents
|
|
TW201315711A
|
|
Compositions, methods, and systems for the synthesis and use of imaging agents
|
|
CA2852395A1
|
|
Compositions comprising ascorbic acid and pyridaben and pyridaben analogs attached to an imaging moiety and related methods
|
|
AU2011253052A1
|
|
Compositions, methods and systems for the synthesis and use of imaging agents
|
|
CA2789044A1
|
|
Methods and apparatus for synthesizing imaging agents, and intermediates thereof
|
|
EP2451776A2
|
|
N-alkoxyamide conjugates as imaging agents
|
